The FDA record for K261361 identifies Carl Zeiss Meditec, AG, at Rudolf-Eber-Strasse 11, Oberkochen, Germany, as the applicant for the TORUS Ultrasonic Aspirator System and accessories, including TORUS Single-Use Tubing Sets, Single-Use Torque Wrenches, Handpieces, Tip Packs and a Tip Clearing Stylet. The submission was received April 27, 2026, reviewed as a Traditional 510(k) without third-party review, and decided October 15, 2026 as substantially equivalent, with a summary on file. The device is listed under product code LFL, described in the openFDA fields as an ultrasonic surgical instrument. [1][2]
What the clearance covers
The K261361 record covers a system plus consumable and accessory components rather than a single instrument. The named accessories are tubing sets, torque wrenches, handpieces, tip packs and a tip clearing stylet. The decision code is SESE and the decision description reads Substantially Equivalent. The record carries a statement or summary designation of Summary and an expedited review flag that is blank, so no expedited status is documented. [1][6]
The FDA final-decisions listing for October 15, 2026 shows K261361 with the same device name and applicant, alongside other clearances decided that day. That listing is a decision feed, not a measure of commercial launch, installed base or sales. [6]
Documented product configuration
ZEISS published documentation describes the TORUS Ultrasonic Aspirator with three dedicated handpieces within one system: an angled longitudinal handpiece for soft and fibrous tissue removal, a straight longitudinal handpiece for ultrasonic bone cutting, and a torsional handpiece for bone rasping. The same brochure maps ten tips to those handpieces, including standard, micro, macro and shark tips for soft or fibrous work, serrated double-sided knife and 20 mm and 10 mm ultrasonic knives for bone cutting, and 360, micro and open-angle rasp tips for bone rasping. [4]
The product page states that the product is available for US customers only, and the brochure carries the same US-only statement. The brochure is copyrighted by Carl Zeiss Meditec USA, Inc., 2026, a different legal entity from the FDA applicant; the relationship between the two is not established in these records. [3][4]
Applicant identity and corporate context
The applicant of record is Carl Zeiss Meditec, AG, with a German country code and an Oberkochen address taken from the filing. That address is a filing address and is not treated here as a verified headquarters. The same October 15 feed lists a separate clearance, K262097 for the MICOR 700 System and MICOR 700 Extractor, under the applicant name Carl Zeiss Meditec Cataract Technologies, which is a distinct applicant string in the record. [1][6]
Carl Zeiss Meditec AG's corporate site describes the company as working in ophthalmology and microsurgery with medical products and integrated workflow solutions, citing efforts to preserve eyesight and to combat brain tumors among the applications it addresses. That description is the company's own published positioning. [8]
Portfolio snapshot and limits
As of November 20, 2026, the linked collection contains one 510(k) record, and the decision count for that full collection is one SESE decision. The explicitly smaller record sample also shows one SESE decision. These figures describe the linked filings at that date and are not total company sales, total portfolio or safety performance. [1]
A 9M 2026 analyst conference transcript from Carl Zeiss Meditec AG discusses extending instrument and recurring revenue in MCS and consumables strategy. The available excerpt does not connect that discussion to TORUS or K261361, so any such link remains unknown. [7]



